A 2018 review of sixteen studies of cannabis-based medicines for neuropathic discomfort, almost all of which analyzed a cannabinoid preparing named nabiximols (manufacturer identify Sativex; a mouth spray made up of equally THC and CBD that is approved in some nations although not in the United